Hiroichi Ishikawa
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Epidemiology top 10%
- Molecular Biology
- Surgery
- Co-authors
- Hiroaki SatohKoichi KurishimaMorio OhtsukaKatsunori KagohashiNobuyuki HizawaKiyohisa SekizawaTomohiro TamuraKensuke Nakazawa
- Topics
- Lung Cancer Diagnosis and Treatment (35 papers)Lung Cancer Treatments and Mutations (33 papers)Lung Cancer Research Studies (30 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hiroichi Ishikawa
129 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 107
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 717
- Epidemiology 381
- Molecular Biology 284
- Surgery 231
Countries citing papers authored by Hiroichi Ishikawa
This map shows the geographic impact of Hiroichi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroichi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroichi Ishikawa more than expected).
Fields of papers citing papers by Hiroichi Ishikawa
This network shows the impact of papers produced by Hiroichi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroichi Ishikawa. The network helps show where Hiroichi Ishikawa may publish in the future.
Co-authorship network of co-authors of Hiroichi Ishikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroichi Ishikawa. A scholar is included among the top collaborators of Hiroichi Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroichi Ishikawa. Hiroichi Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | [A case of thymoma and Mycobacterium intracellulare infection]. | 2 |
| 5 | 5 | |
| 6 | Long-term survivors after chemotherapy in advanced non-small cell lung cancer. | 23 |
| 7 | Psychotropic drugs for terminally ill patients with respiratory disease. | 2 |
| 8 | 21 | |
| 9 | 58 | |
| 10 | Body mass index and lung cancer risk in never smokers | 4 |
| 11 | Multiple primary malignancies in patients with lung cancer | 5 |
| 12 | 22 | |
| 13 | 16 | |
| 14 | 2 | |
| 15 | 7 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 1 | |
| 19 | 4 | |
| 20 | 7 |
About Hiroichi Ishikawa
Hiroichi Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases, having authored 132 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (33 papers) and Lung Cancer Research Studies (30 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Oncology (717 citations) and Applied Microbiology and Biotechnology (23 citations). Hiroichi Ishikawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Hiroaki Satoh, Koichi Kurishima, Morio Ohtsuka, Katsunori Kagohashi, Nobuyuki Hizawa, Kiyohisa Sekizawa, Tomohiro Tamura, Kensuke Nakazawa, Hiromichi Suzuki and Takahide Kodama. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.